Novozymes has been growing earnings at an average annual rate of 4.4%, while the Chemicals industry saw earnings growing at 3% annually. Revenues have been growing at an average rate of 18.7% per year. Novozymes's return on equity is 5.5%, and it has net margins of 14.2%.
Key information
4.40%
Earnings growth rate
-2.32%
EPS growth rate
Chemicals Industry Growth
4.35%
Revenue growth rate
18.74%
Return on equity
5.46%
Net Margin
14.21%
Next Earnings Update
20 Aug 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Novozymes makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BATS-CHIXE:NSISBC Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
4,199
597
944
462
31 Dec 25
4,158
584
912
449
30 Sep 25
4,142
547
872
446
30 Jun 25
4,098
565
839
436
31 Mar 25
4,058
459
810
429
31 Dec 24
3,834
306
766
413
30 Sep 24
3,471
314
669
373
30 Jun 24
3,047
283
575
327
31 Mar 24
2,636
334
494
293
31 Dec 23
2,402
406
446
271
30 Sep 23
2,390
430
441
270
30 Jun 23
2,382
460
446
272
31 Mar 23
2,390
487
441
270
31 Dec 22
2,360
494
430
267
30 Sep 22
2,268
460
443
262
30 Jun 22
2,186
418
418
257
31 Mar 22
2,090
416
403
257
31 Dec 21
2,009
423
380
266
30 Sep 21
1,958
427
335
268
30 Jun 21
1,914
409
322
274
31 Mar 21
1,883
389
310
270
31 Dec 20
1,883
380
309
256
30 Sep 20
1,920
415
309
248
30 Jun 20
1,955
405
326
254
31 Mar 20
1,968
439
335
264
31 Dec 19
1,924
422
329
263
30 Sep 19
1,923
411
334
262
30 Jun 19
1,917
434
321
260
31 Mar 19
1,922
417
315
249
31 Dec 18
1,927
432
313
248
30 Sep 18
1,924
427
311
254
30 Jun 18
1,915
429
310
247
31 Mar 18
1,920
423
320
248
31 Dec 17
1,952
419
332
255
30 Sep 17
1,958
421
334
255
30 Jun 17
1,934
412
332
254
31 Mar 17
1,919
414
328
251
31 Dec 16
1,902
410
325
251
30 Sep 16
1,864
394
327
247
30 Jun 16
1,883
394
333
253
31 Mar 16
1,883
384
331
259
31 Dec 15
1,876
378
330
254
30 Sep 15
1,840
366
320
255
30 Jun 15
1,795
353
314
252
Quality Earnings: NSISBC has high quality earnings.
Growing Profit Margin: NSISBC's current net profit margins (14.2%) are higher than last year (11.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NSISBC's earnings have grown by 4.4% per year over the past 5 years.
Accelerating Growth: NSISBC's earnings growth over the past year (30.1%) exceeds its 5-year average (4.4% per year).
Earnings vs Industry: NSISBC earnings growth over the past year (30.1%) exceeded the Chemicals industry -59.9%.
Return on Equity
High ROE: NSISBC's Return on Equity (5.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/26 15:58
End of Day Share Price
2026/05/26 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novozymes A/S is covered by 28 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.